Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2022		72,585,596
Beginning balance at Dec. 31, 2022	$ 3,091,784	$ 726	$ 1,784,173	$ 1,306,885	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	80,700			80,700
Other comprehensive income (loss)	323				323
Shares issued under stock-based compensation programs, net (in shares)		503,022
Shares issued under stock-based compensation programs, net	(11,740)	$ 5	(11,745)
Cash dividends declared	(36,543)			(36,543)
Stock-based compensation expense	5,597		5,597
Forfeiture of restricted stock (in shares)		(1,283)
Ending balance (in shares) at Mar. 31, 2023		73,087,335
Ending balance at Mar. 31, 2023	3,130,121	$ 731	1,778,025	1,351,042	323
Beginning balance (in shares) at Dec. 31, 2022		72,585,596
Beginning balance at Dec. 31, 2022	3,091,784	$ 726	1,784,173	1,306,885	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	174,193
Other comprehensive income (loss)	90
Ending balance (in shares) at Jun. 30, 2023		74,544,221
Ending balance at Jun. 30, 2023	3,221,103	$ 745	1,812,299	1,407,969	90
Beginning balance (in shares) at Mar. 31, 2023		73,087,335
Beginning balance at Mar. 31, 2023	3,130,121	$ 731	1,778,025	1,351,042	323
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	93,493			93,493
Other comprehensive income (loss)	(233)				(233)
Shares issued under stock-based compensation programs, net (in shares)		1,459,256
Shares issued under stock-based compensation programs, net	31,332	$ 14	31,318
Cash dividends declared	(36,566)			(36,566)
Stock-based compensation expense	2,956		2,956
Forfeiture of restricted stock (in shares)		(2,370)
Ending balance (in shares) at Jun. 30, 2023		74,544,221
Ending balance at Jun. 30, 2023	$ 3,221,103	$ 745	1,812,299	1,407,969	90
Beginning balance (in shares) at Dec. 31, 2023	74,661,479	74,661,479
Beginning balance at Dec. 31, 2023	$ 3,377,885	$ 747	1,824,434	1,552,653	51
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	95,819			95,819
Other comprehensive income (loss)	(47)				(47)
Shares issued under stock-based compensation programs, net (in shares)		386,523
Shares issued under stock-based compensation programs, net	(25,626)	$ 3	(25,629)
Cash dividends declared	(41,276)			(41,276)
Stock-based compensation expense	2,632		2,632
Forfeiture of restricted stock (in shares)		(301)
Ending balance (in shares) at Mar. 31, 2024		75,047,701
Ending balance at Mar. 31, 2024	$ 3,409,387	$ 750	1,801,437	1,607,196	4
Beginning balance (in shares) at Dec. 31, 2023	74,661,479	74,661,479
Beginning balance at Dec. 31, 2023	$ 3,377,885	$ 747	1,824,434	1,552,653	51
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	120,953
Other comprehensive income (loss)	$ (27)
Ending balance (in shares) at Jun. 30, 2024	100	100
Ending balance at Jun. 30, 2024	$ 2,830,088	$ 0	1,197,734	1,632,330	24
Beginning balance (in shares) at Mar. 31, 2024		75,047,701
Beginning balance at Mar. 31, 2024	3,409,387	$ 750	1,801,437	1,607,196	4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	25,134			25,134
Other comprehensive income (loss)	20				20
Shares issued under stock-based compensation programs, net (in shares)		1,653
Shares issued under stock-based compensation programs, net	28	$ 0	28
Stock-based compensation expense	173		173
Effect of merger transaction (in shares)		(75,049,254)
Effect of Merger transaction	$ (604,654)	$ (750)	(603,904)
Ending balance (in shares) at Jun. 30, 2024	100	100
Ending balance at Jun. 30, 2024	$ 2,830,088	$ 0	$ 1,197,734	$ 1,632,330	$ 24